查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1508535

心肌肌钙蛋白市场（肌钙蛋白类型：肌钙蛋白I、肌钙蛋白T 和肌钙蛋白C，以及环境：实验室环境和护理点(POC) 测试）- 2024 年全球产业分析、规模、份额、成长、趋势和预测-2034

Cardiac Troponin Market (Troponin Type: Troponin I, Troponin T, and Tropinin C, and Setting: Laboratory Setting and Point-of-Care (POC) Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 176 Pages | 商品交期: 2-10个工作天内

价格

心肌肌钙蛋白市场 - 报告范围

TMR 关于全球心肌肌钙蛋白市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 -2034年期间，考虑2024年为基准年，2034年为预测年。报告也提供了2024年至2034年全球心肌肌钙蛋白市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解心肌肌钙蛋白市场。

市场概况
2023年市场价值 45 亿美元
2034 年市场价值 115 亿美元
复合年增长率 8.9%

该报告深入研究了全球心肌肌钙蛋白市场的竞争格局。全球心肌肌钙蛋白市场的主要参与者已被确定，并且每位参与者都已根据各种属性进行了分析。公司概况、财务状况、近期发展和 SWOT 是本报告中介绍的全球心肌肌钙蛋白市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：按肌钙蛋白类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按肌钙蛋白类型，2020-2034
    • 肌钙蛋白I
    • 肌钙蛋白T
    • 肌钙蛋白C
  • 市场吸引力：按肌钙蛋白类型

第 7 章：全球市场分析与预测：按设置

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依设定，2020-2034
    • 实验室环境
    • 即时护理 (POC) 测试
  • 市场吸引力：按设置

第 8 章：全球市场分析与预测：依指标分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依指标划分，2020-2034
    • 心肌梗塞
    • 充血性心臟衰竭
    • 急性冠状动脉综合症
    • 其他（心肌病变等）
  • 市场吸引力：依指标分类

第 9 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2034
    • 医院和诊所
    • 诊断实验室
    • 家庭护理设置
    • 其他（研究所等）
  • 市场吸引力：按最终用户划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • F. Hoffmann-La Roche Ltd.
    • bioMerieux SA
    • Abbott Laboratories
    • Siemens Healthineers India
    • Eurolyser Diagnostica GmbH
    • QuidelOrtho Corporation
    • Beckman Coulter, Inc.
    • Response Biomedical Corporation
    • LifeSign LLC
Product Code: TMRGL86112

Cardiac Troponin Market - Scope of Report

TMR's report on the global cardiac troponin market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global cardiac troponin market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cardiac troponin market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cardiac troponin market.

Market Snapshot
Market Value in 2023US$ 4.5 Bn
Market Value in 2034US$ 11.5 Bn
CAGR8.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cardiac troponin market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cardiac troponin market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cardiac troponin market.

The report delves into the competitive landscape of the global cardiac troponin market. Key players operating in the global cardiac troponin market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cardiac troponin market profiled in this report.

Key Questions Answered in Global cardiac troponin Market Report:

  • What is the sales/revenue generated by cardiac troponin across all regions during the forecast period?
  • What are the opportunities in the global cardiac troponin market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cardiac Troponin Market - Research Objectives and Research Approach

The comprehensive report on the global cardiac troponin market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cardiac troponin market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cardiac troponin market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiac Troponin Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cardiac Troponin Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Cardiac Troponin Market Analysis and Forecast, by Troponin Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Troponin Type, 2020-2034
    • 6.3.1. Troponin I
    • 6.3.2. Troponin T
    • 6.3.3. Troponin C
  • 6.4. Market Attractiveness, by Troponin Type

7. Global Cardiac Troponin Market Analysis and Forecast, by Setting

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Setting, 2020-2034
    • 7.3.1. Laboratory Setting
    • 7.3.2. Point-of-Care (POC) Testing
  • 7.4. Market Attractiveness, by Setting

8. Global Cardiac Troponin Market Analysis and Forecast, by Indication

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Indication, 2020-2034
    • 8.3.1. Myocardial Infarction
    • 8.3.2. Congestive Heart Failure
    • 8.3.3. Acute Coronary Syndrome
    • 8.3.4. Others (cardiomyopathy, etc.)
  • 8.4. Market Attractiveness, by Indication

9. Global Cardiac Troponin Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Hospitals & Clinics
    • 9.3.2. Diagnostic Laboratories
    • 9.3.3. Homecare Settings
    • 9.3.4. Others (Research Institutes, etc.)
  • 9.4. Market Attractiveness, by End-user

10. Global Cardiac Troponin Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Cardiac Troponin Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Troponin Type, 2020-2034
    • 11.2.1. Troponin I
    • 11.2.2. Troponin T
    • 11.2.3. Troponin C
  • 11.3. Market Attractiveness, by Troponin Type
  • 11.4. Market Value Forecast, by Setting, 2020-2034
    • 11.4.1. Laboratory Setting
    • 11.4.2. Point-of-Care (POC) Testing
  • 11.5. Market Attractiveness, by Setting
  • 11.6. Market Value Forecast, by Indication, 2020-2034
    • 11.6.1. Myocardial Infarction
    • 11.6.2. Congestive Heart Failure
    • 11.6.3. Acute Coronary Syndrome
    • 11.6.4. Others (cardiomyopathy, etc.)
  • 11.7. Market Attractiveness, by Indication
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Hospitals & Clinics
    • 11.8.2. Diagnostic Laboratories
    • 11.8.3. Homecare Settings
    • 11.8.4. Others (Research Institutes, etc.)
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Troponin Type
    • 11.11.2. By Setting
    • 11.11.3. By Indication
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Cardiac Troponin Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Troponin Type, 2020-2034
    • 12.2.1. Troponin I
    • 12.2.2. Troponin T
    • 12.2.3. Troponin C
  • 12.3. Market Attractiveness, by Troponin Type
  • 12.4. Market Value Forecast, by Setting, 2020-2034
    • 12.4.1. Laboratory Setting
    • 12.4.2. Point-of-Care (POC) Testing
  • 12.5. Market Attractiveness, by Setting
  • 12.6. Market Value Forecast, by Indication, 2020-2034
    • 12.6.1. Myocardial Infarction
    • 12.6.2. Congestive Heart Failure
    • 12.6.3. Acute Coronary Syndrome
    • 12.6.4. Others (cardiomyopathy, etc.)
  • 12.7. Market Attractiveness, by Indication
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Hospitals & Clinics
    • 12.8.2. Diagnostic Laboratories
    • 12.8.3. Homecare Settings
    • 12.8.4. Others (Research Institutes, etc.)
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Troponin Type
    • 12.11.2. By Setting
    • 12.11.3. By Indication
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Cardiac Troponin Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Troponin Type, 2020-2034
    • 13.2.1. Troponin I
    • 13.2.2. Troponin T
    • 13.2.3. Troponin C
  • 13.3. Market Attractiveness, by Troponin Type
  • 13.4. Market Value Forecast, by Setting, 2020-2034
    • 13.4.1. Laboratory Setting
    • 13.4.2. Point-of-Care (POC) Testing
  • 13.5. Market Attractiveness, by Setting
  • 13.6. Market Value Forecast, by Indication, 2020-2034
    • 13.6.1. Myocardial Infarction
    • 13.6.2. Congestive Heart Failure
    • 13.6.3. Acute Coronary Syndrome
    • 13.6.4. Others (cardiomyopathy, etc.)
  • 13.7. Market Attractiveness, by Indication
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Hospitals & Clinics
    • 13.8.2. Diagnostic Laboratories
    • 13.8.3. Homecare Settings
    • 13.8.4. Others (Research Institutes, etc.)
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Troponin Type
    • 13.11.2. By Setting
    • 13.11.3. By Indication
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Cardiac Troponin Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Troponin Type, 2020-2034
    • 14.2.1. Troponin I
    • 14.2.2. Troponin T
    • 14.2.3. Troponin C
  • 14.3. Market Attractiveness, by Troponin Type
  • 14.4. Market Value Forecast, by Setting, 2020-2034
    • 14.4.1. Laboratory Setting
    • 14.4.2. Point-of-Care (POC) Testing
  • 14.5. Market Attractiveness, by Setting
  • 14.6. Market Value Forecast, by Indication, 2020-2034
    • 14.6.1. Myocardial Infarction
    • 14.6.2. Congestive Heart Failure
    • 14.6.3. Acute Coronary Syndrome
    • 14.6.4. Others (cardiomyopathy, etc.)
  • 14.7. Market Attractiveness, by Indication
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Hospitals & Clinics
    • 14.8.2. Diagnostic Laboratories
    • 14.8.3. Homecare Settings
    • 14.8.4. Others (Research Institutes, etc.)
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Troponin Type
    • 14.11.2. By Setting
    • 14.11.3. By Indication
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Cardiac Troponin Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Troponin Type, 2020-2034
    • 15.2.1. Troponin I
    • 15.2.2. Troponin T
    • 15.2.3. Troponin C
  • 15.3. Market Attractiveness, by Troponin Type
  • 15.4. Market Value Forecast, by Setting, 2020-2034
    • 15.4.1. Laboratory Setting
    • 15.4.2. Point-of-Care (POC) Testing
  • 15.5. Market Attractiveness, by Setting
  • 15.6. Market Value Forecast, by Indication, 2020-2034
    • 15.6.1. Myocardial Infarction
    • 15.6.2. Congestive Heart Failure
    • 15.6.3. Acute Coronary Syndrome
    • 15.6.4. Others (cardiomyopathy, etc.)
  • 15.7. Market Attractiveness, by Indication
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Hospitals & Clinics
    • 15.8.2. Diagnostic Laboratories
    • 15.8.3. Homecare Settings
    • 15.8.4. Others (Research Institutes, etc.)
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Troponin Type
    • 15.11.2. By Setting
    • 15.11.3. By Indication
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. F. Hoffmann-La Roche Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. bioMerieux SA
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Abbott Laboratories
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Siemens Healthineers India
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Eurolyser Diagnostica GmbH
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. QuidelOrtho Corporation
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Beckman Coulter, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Response Biomedical Corporation
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. LifeSign LLC
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Cardiac Troponin Market Size (US$ Bn) Forecast, by Troponin Type, 2020-2034
  • Table 02: Global Cardiac Troponin Market Size (US$ Bn) Forecast, by Setting, 2020-2034
  • Table 03: Global Cardiac Troponin Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Cardiac Troponin Market Size (US$ Bn) Forecast, by Indication, 2020-2034
  • Table 05: Global Cardiac Troponin Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 06: North America Cardiac Troponin Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 07: North America Cardiac Troponin Market Size (US$ Bn) Forecast, by Troponin Type, 2020-2034
  • Table 08: North America Cardiac Troponin Market Size (US$ Bn) Forecast, by Setting, 2020-2034
  • Table 09: North America Cardiac Troponin Market Size (US$ Bn) Forecast, by Indication, 2020-2034
  • Table 10: North America Cardiac Troponin Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Cardiac Troponin Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Cardiac Troponin Market Size (US$ Bn) Forecast, by Troponin Type, 2020-2034
  • Table 13: Europe Cardiac Troponin Market Size (US$ Bn) Forecast, by Setting, 2020-2034
  • Table 14: Europe Cardiac Troponin Market Size (US$ Bn) Forecast, by Indication, 2020-2034
  • Table 15: Europe Cardiac Troponin Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Cardiac Troponin Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Cardiac Troponin Market Size (US$ Bn) Forecast, by Troponin Type, 2020-2034
  • Table 18: Asia Pacific Cardiac Troponin Market Size (US$ Bn) Forecast, by Setting, 2020-2034
  • Table 19: Asia Pacific Cardiac Troponin Market Size (US$ Bn) Forecast, by Indication, 2020-2034
  • Table 20: Asia Pacific Cardiac Troponin Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Cardiac Troponin Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Cardiac Troponin Market Size (US$ Bn) Forecast, by Troponin Type, 2020-2034
  • Table 23: Latin America Cardiac Troponin Market Size (US$ Bn) Forecast, by Setting, 2020-2034
  • Table 24: Latin America Cardiac Troponin Market Size (US$ Bn) Forecast, by Indication, 2020-2034
  • Table 25: Latin America Cardiac Troponin Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Cardiac Troponin Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Cardiac Troponin Market Size (US$ Bn) Forecast, by Troponin Type, 2020-2034
  • Table 28: Middle East & Africa Cardiac Troponin Market Size (US$ Bn) Forecast, by Setting, 2020-2034
  • Table 29: Middle East & Africa Cardiac Troponin Market Size (US$ Bn) Forecast, by Indication, 2020-2034
  • Table 30: Middle East & Africa Cardiac Troponin Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Cardiac Troponin Market Size (US$ Bn), by Region, 2023 and 2034
  • Figure 02: Global Cardiac Troponin Market Revenue (US$ Bn), by Troponin Type, 2023
  • Figure 03: Global Cardiac Troponin Market Value Share, by Troponin Type, 2023
  • Figure 04: Global Cardiac Troponin Market Revenue (US$ Bn), by Setting, 2023
  • Figure 05: Global Cardiac Troponin Market Value Share, by Setting, 2023
  • Figure 06: Global Cardiac Troponin Market Revenue (US$ Bn), by Indication, 2023
  • Figure 07: Global Cardiac Troponin Market Value Share, by Indication, 2023
  • Figure 08: Global Cardiac Troponin Market Revenue (US$ Bn), by End-user, 2023
  • Figure 09: Global Cardiac Troponin Market Value Share, by End-user, 2023
  • Figure 10: Global Cardiac Troponin Market Value Share, by Region, 2023
  • Figure 11: Global Cardiac Troponin Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 12: Global Cardiac Troponin Market Value Share Analysis, by Troponin Type, 2023 and 2034
  • Figure 13: Global Cardiac Troponin Market Attractiveness Analysis, by Troponin Type, 2024-2034
  • Figure 14: Global Cardiac Troponin Market Value Share Analysis, by Setting, 2023 and 2034
  • Figure 15: Global Cardiac Troponin Market Attractiveness Analysis, by Setting, 2024-2034
  • Figure 16: Global Cardiac Troponin Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 17: Global Cardiac Troponin Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 18: Global Cardiac Troponin Market Revenue (US$ Bn), by End-user, 2023
  • Figure 19: Global Cardiac Troponin Market Value Share, by End-user, 2023
  • Figure 20: Global Cardiac Troponin Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global Cardiac Troponin Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America Cardiac Troponin Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America Cardiac Troponin Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Cardiac Troponin Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America Cardiac Troponin Market Value Share Analysis, by Troponin Type, 2023 and 2034
  • Figure 26: North America Cardiac Troponin Market Value Share Analysis, by Setting, 2023 and 2034
  • Figure 27: North America Cardiac Troponin Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 28: North America Cardiac Troponin Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 29: North America Cardiac Troponin Market Attractiveness Analysis, by Troponin Type, 2024-2034
  • Figure 30: North America Cardiac Troponin Market Attractiveness Analysis, by Setting, 2024-2034
  • Figure 31: North America Cardiac Troponin Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 32: North America Cardiac Troponin Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Cardiac Troponin Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe Cardiac Troponin Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe Cardiac Troponin Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe Cardiac Troponin Market Value Share Analysis, by Troponin Type, 2023 and 2034
  • Figure 37: Europe Cardiac Troponin Market Value Share Analysis, by Setting, 2023 and 2034
  • Figure 38: Europe Cardiac Troponin Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 39: Europe Cardiac Troponin Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 40: Europe Cardiac Troponin Market Attractiveness Analysis, by Troponin Type, 2024-2034
  • Figure 41: Europe Cardiac Troponin Market Attractiveness Analysis, by Setting, 2024-2034
  • Figure 42: Europe Cardiac Troponin Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 43: Europe Cardiac Troponin Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Cardiac Troponin Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific Cardiac Troponin Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific Cardiac Troponin Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific Cardiac Troponin Market Value Share Analysis, by Troponin Type, 2023 and 2034
  • Figure 48: Asia Pacific Cardiac Troponin Market Value Share Analysis, by Setting, 2023 and 2034
  • Figure 49: Asia Pacific Cardiac Troponin Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 50: Asia Pacific Cardiac Troponin Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Asia Pacific Cardiac Troponin Market Attractiveness Analysis, by Troponin Type, 2024-2034
  • Figure 52: Asia Pacific Cardiac Troponin Market Attractiveness Analysis, by Setting, 2024-2034
  • Figure 53: Asia Pacific Cardiac Troponin Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 54: Asia Pacific Cardiac Troponin Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 55: Latin America Cardiac Troponin Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America Cardiac Troponin Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America Cardiac Troponin Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America Cardiac Troponin Market Value Share Analysis, by Troponin Type, 2023 and 2034
  • Figure 59: Latin America Cardiac Troponin Market Value Share Analysis, by Setting, 2023 and 2034
  • Figure 60: Latin America Cardiac Troponin Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 61: Latin America Cardiac Troponin Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 62: Latin America Cardiac Troponin Market Attractiveness Analysis, by Troponin Type, 2024-2034
  • Figure 63: Latin America Cardiac Troponin Market Attractiveness Analysis, by Setting, 2024-2034
  • Figure 64: Latin America Cardiac Troponin Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 65: Latin America Cardiac Troponin Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Cardiac Troponin Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa Cardiac Troponin Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa Cardiac Troponin Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa Cardiac Troponin Market Value Share Analysis, by Troponin Type, 2023 and 2034
  • Figure 70: Middle East & Africa Cardiac Troponin Market Value Share Analysis, by Setting, 2023 and 2034
  • Figure 71: Middle East & Africa Cardiac Troponin Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 72: Middle East & Africa Cardiac Troponin Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Middle East & Africa Cardiac Troponin Market Attractiveness Analysis, by Troponin Type, 2024-2034
  • Figure 74: Middle East & Africa Cardiac Troponin Market Attractiveness Analysis, by Setting, 2024-2034
  • Figure 75: Middle East & Africa Cardiac Troponin Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 76: Middle East & Africa Cardiac Troponin Market Attractiveness Analysis, by End-user, 2024-2034